Concorde Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,826
Closed -$612K 198
2021
Q3
$612K Buy
4,826
+3,586
+289% +$522K 0.35% 96
2021
Q2
$206K Sell
1,240
-572
-32% -$92.7K 0.12% 184
2021
Q1
$330K Sell
1,812
-10,324
-85% -$2.39M 0.19% 135
2020
Q4
$2.43M Buy
+12,136
New +$2.47M 1.35% 17

Other funds holding TDOC

Concorde Asset Management's TDOC Position: Q4 2021 in Review

Concorde Asset Management sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 4,826 shares — an estimated $612K sold.

Concorde Asset Management first reported a position in TDOC in Q4 2020 and held it in 4 quarters. The position peaked at $2.43M in Q4 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Concorde Asset Management reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Concorde Asset Management sold 4,826 Teladoc Health shares in Q4 2021, an estimated $612K.
  • Concorde Asset Management first reported a position in Teladoc Health in Q4 2020 and held it in 4 quarters.
  • Concorde Asset Management's Teladoc Health position peaked at $2.43M in Q4 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Concorde Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.